MoneyWorks4Me

Tyche Inds - Quaterly Results

13 Feb 2023 Evaluate
The sales figure stood at Rs. 200.36 millions for the December 2022 quarter. The mentioned figure indicates a growth of about 37.51% as compared to Rs. 145.71 millions during the year-ago period.The Net Profit of the company vaulted to 152.10% to Rs. 45.68  millions from Rs. 18.12 millions in the previous quarter.Operating profit surged to 66.56 millions from the corresponding previous quarter of 26.76 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 200.36 145.71 37.51 500.98 460.02 8.90 622.67 782.40 -20.42
Other Income 12.18 12.24 -0.49 38.89 29.58 31.47 41.56 47.40 -12.32
PBIDT 66.56 26.76 148.73 148.81 116.05 28.23 151.17 294.45 -48.66
Interest 0.01 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00
PBDT 65.35 27.36 138.85 147.60 116.65 26.53 144.23 284.56 -49.31
Depreciation 4.34 4.65 -6.67 12.98 13.69 -5.19 17.89 17.22 3.89
PBT 61.01 22.71 168.65 134.62 102.96 30.75 126.34 267.34 -52.74
TAX 15.33 4.59 233.99 33.94 25.02 35.65 33.04 67.51 -51.06
Deferred Tax 0.63 -1.71 -136.84 -0.72 -1.98 -63.64 -0.86 0.21 -509.52
PAT 45.68 18.12 152.10 100.68 77.94 29.18 93.30 199.83 -53.31
Equity 102.45 102.45 0.00 102.45 102.45 0.00 102.45 102.45 0.00
PBIDTM(%) 33.22 18.37 80.89 29.70 25.23 17.75 24.28 37.63 -35.49
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..